|
EP4610368A3
(en)
|
2013-08-05 |
2025-11-05 |
Twist Bioscience Corporation |
De novo synthesized gene libraries
|
|
US10669304B2
(en)
|
2015-02-04 |
2020-06-02 |
Twist Bioscience Corporation |
Methods and devices for de novo oligonucleic acid assembly
|
|
WO2016172377A1
(en)
|
2015-04-21 |
2016-10-27 |
Twist Bioscience Corporation |
Devices and methods for oligonucleic acid library synthesis
|
|
HK1258869A1
(zh)
|
2015-09-18 |
2019-11-22 |
Twist Bioscience Corporation |
寡核酸变体文库及其合成
|
|
US11512347B2
(en)
|
2015-09-22 |
2022-11-29 |
Twist Bioscience Corporation |
Flexible substrates for nucleic acid synthesis
|
|
CN108603307A
(zh)
|
2015-12-01 |
2018-09-28 |
特韦斯特生物科学公司 |
功能化表面及其制备
|
|
GB201604458D0
(en)
|
2016-03-16 |
2016-04-27 |
Immatics Biotechnologies Gmbh |
Peptides and combination of peptides for use in immunotherapy against cancers
|
|
FI3430030T3
(fi)
|
2016-03-16 |
2024-01-16 |
Immatics Biotechnologies Gmbh |
Transfektoituja t-soluja ja t-solureseptoreita käytettäviksi syöpien immunoterapiassa
|
|
AU2017315294B2
(en)
|
2016-08-22 |
2023-12-21 |
Twist Bioscience Corporation |
De novo synthesized nucleic acid libraries
|
|
EP4664304A2
(en)
|
2016-09-21 |
2025-12-17 |
Atlas Data Storage, Inc. |
Nucleic acid based data storage
|
|
DE102016123847B3
(de)
*
|
2016-12-08 |
2018-04-05 |
Immatics Biotechnologies Gmbh |
Neue T-Zellrezeptoren und deren Verwendung in Immuntherapie
|
|
MD3551221T2
(ro)
|
2016-12-08 |
2022-04-30 |
Immatics Biotechnologies Gmbh |
Noi receptori de celule T și imunoterapie cu utilizarea acestora
|
|
AU2017378492B2
(en)
|
2016-12-16 |
2022-06-16 |
Twist Bioscience Corporation |
Variant libraries of the immunological synapse and synthesis thereof
|
|
CA3054303A1
(en)
|
2017-02-22 |
2018-08-30 |
Twist Bioscience Corporation |
Nucleic acid based data storage
|
|
CA3056388A1
(en)
|
2017-03-15 |
2018-09-20 |
Twist Bioscience Corporation |
Variant libraries of the immunological synapse and synthesis thereof
|
|
AU2018251839B2
(en)
*
|
2017-04-10 |
2022-06-30 |
Immatics Biotechnologies Gmbh |
Peptides and combination thereof for use in the immunotherapy against cancers
|
|
KR102784398B1
(ko)
|
2017-06-12 |
2025-03-19 |
트위스트 바이오사이언스 코포레이션 |
심리스 핵산 어셈블리를 위한 방법
|
|
WO2018231864A1
(en)
|
2017-06-12 |
2018-12-20 |
Twist Bioscience Corporation |
Methods for seamless nucleic acid assembly
|
|
CN111566125A
(zh)
|
2017-09-11 |
2020-08-21 |
特韦斯特生物科学公司 |
Gpcr结合蛋白及其合成
|
|
CN111787930B
(zh)
*
|
2017-10-06 |
2024-12-20 |
芝加哥大学 |
针对癌症特异性抗原对t淋巴细胞的筛选
|
|
AU2018346957B2
(en)
*
|
2017-10-12 |
2024-08-01 |
Board Of Regents, The University Of Texas System |
T cell receptors for immunotherapy
|
|
WO2019079769A1
(en)
|
2017-10-20 |
2019-04-25 |
Twist Bioscience Corporation |
HEATED NANOWELLS FOR THE SYNTHESIS OF POLYNUCLEOTIDES
|
|
EP3735459A4
(en)
|
2018-01-04 |
2021-10-06 |
Twist Bioscience Corporation |
DNA-BASED DIGITAL INFORMATION STORAGE
|
|
GB201803750D0
(en)
|
2018-03-08 |
2018-04-25 |
Immunocore Ltd |
Method
|
|
DE102018108612A1
(de)
|
2018-03-21 |
2019-09-26 |
Immatics US, Inc. |
Verfahren zur erhöhung der persistenz von adoptiv infundierten t-zellen
|
|
WO2019196088A1
(en)
*
|
2018-04-13 |
2019-10-17 |
Syz Cell Therapy Co. |
Methods of obtaining tumor-specific t cell receptors
|
|
IL278771B2
(en)
|
2018-05-18 |
2025-09-01 |
Twist Bioscience Corp |
Polynucleotides, reagents and methods for nucleic acid hybridization
|
|
WO2020049496A1
(en)
*
|
2018-09-05 |
2020-03-12 |
Glaxosmithkline Intellectual Property Development Limited |
T cell modification
|
|
JP7528058B2
(ja)
*
|
2018-09-14 |
2024-08-05 |
イマティクス バイオテクノロジーズ ゲーエムベーハー |
Ｔｃｒリガンドの高スループットペプチド－ｍｈｃ親和性スクリーニングのための方法
|
|
DE102018122546B3
(de)
|
2018-09-14 |
2019-12-05 |
Immatics Biotechnologies Gmbh |
Verfahren zum Hochdurchsatz-Peptid-MHC-Affinitätsscreening für TCR-Liganden
|
|
WO2020139871A1
(en)
|
2018-12-26 |
2020-07-02 |
Twist Bioscience Corporation |
Highly accurate de novo polynucleotide synthesis
|
|
WO2020176680A1
(en)
|
2019-02-26 |
2020-09-03 |
Twist Bioscience Corporation |
Variant nucleic acid libraries for antibody optimization
|
|
EP3930753A4
(en)
|
2019-02-26 |
2023-03-29 |
Twist Bioscience Corporation |
VARIANT NUCLEIC ACID LIBRARIES FOR GLP1 RECEPTOR
|
|
DE102019108125B4
(de)
|
2019-03-28 |
2022-02-03 |
Immatics US, Inc. |
Cd28 t-zellkulturen, zusammensetzungen und verfahren zu deren verwendung
|
|
WO2020191172A1
(en)
|
2019-03-19 |
2020-09-24 |
Immatics US, Inc. |
Cd28 t cell cultures, compositions, and methods of using thereof
|
|
EP3714941A1
(en)
|
2019-03-27 |
2020-09-30 |
Medigene Immunotherapies GmbH |
Mage-a4 tcrs
|
|
CN111748029B
(zh)
*
|
2019-03-29 |
2022-12-13 |
苏州蓝马医疗技术有限公司 |
一种针对egfr l858r基因突变的特异性t细胞受体及其应用
|
|
CN111748028A
(zh)
*
|
2019-03-29 |
2020-10-09 |
天津亨佳生物科技发展有限公司 |
一种针对egfr l858r基因突变的特异性t细胞受体及其应用
|
|
EP3966235A4
(en)
*
|
2019-05-08 |
2023-08-09 |
Medigene Immunotherapies GmbH |
Engineered t cells
|
|
EA202193139A1
(ru)
|
2019-05-27 |
2022-03-01 |
Имматикс Юс, Инк. |
Вирусные векторы и их применение в адоптивной клеточной терапии
|
|
PH12021553152A1
(en)
*
|
2019-06-18 |
2022-08-15 |
Regeneron Pharma |
Mage-a4 t cell receptors and methods of use thereof
|
|
CA3144054A1
(en)
*
|
2019-06-20 |
2020-12-24 |
Memorial Sloan-Kettering Cancer Center |
T cell receptors targeting pik3ca mutations and uses thereof
|
|
EP3987019A4
(en)
|
2019-06-21 |
2023-04-19 |
Twist Bioscience Corporation |
Barcode-based nucleic acid sequence assembly
|
|
CN110357953B
(zh)
*
|
2019-07-17 |
2022-05-03 |
深圳市因诺转化医学研究院 |
识别人巨细胞病毒pp65抗原的TCR
|
|
MX2022001211A
(es)
*
|
2019-07-30 |
2022-05-03 |
Univ Health Network |
Moléculas del complejo mayor de histocompatibilidad (mhc) de clase ii y métodos para su uso.
|
|
DE102019121007A1
(de)
*
|
2019-08-02 |
2021-02-04 |
Immatics Biotechnologies Gmbh |
Antigenbindende Proteine, die spezifisch an MAGE-A binden
|
|
US20210032370A1
(en)
|
2019-08-02 |
2021-02-04 |
Immatics Biotechnologies Gmbh |
Recruiting agent further binding an mhc molecule
|
|
CN115023440B
(zh)
|
2019-09-23 |
2025-09-12 |
特韦斯特生物科学公司 |
结合CD3ε的抗体
|
|
WO2021061829A1
(en)
|
2019-09-23 |
2021-04-01 |
Twist Bioscience Corporation |
Variant nucleic acid libraries for crth2
|
|
AU2021206644A1
(en)
*
|
2020-01-06 |
2022-07-28 |
Memorial Hospital For Cancer And Allied Diseases |
Novel dominant negative Fas polypeptides, cells comprising thereof and uses thereof
|
|
KR20230012465A
(ko)
|
2020-02-24 |
2023-01-26 |
이매틱스 유에스 인코포레이티드 |
암 및 관련 악성 종양을 치료하기 위해 t 세포를 확장하는 방법
|
|
DE102020111571A1
(de)
|
2020-03-11 |
2021-09-16 |
Immatics US, Inc. |
Wpre-mutantenkonstrukte, zusammensetzungen und zugehörige verfahren
|
|
TW202227616A
(zh)
*
|
2020-08-21 |
2022-07-16 |
美商英麥提克斯股份有限公司 |
分離ｃｄ８＋選擇ｔ細胞的方法
|
|
EP4227316A4
(en)
*
|
2020-10-07 |
2025-07-30 |
Daan Biotherapeutics Co., Ltd. |
T CELL RECEPTOR, IMMUNE CELL COMPRISING T CELL RECEPTOR, AND METHOD USING THE SAME
|
|
DE102021100038A1
(de)
|
2020-12-31 |
2022-06-30 |
Immatics US, Inc. |
Modifizierte cd8-polypeptide, zusammensetzungen und verfahren zu deren verwendung
|
|
WO2022147029A2
(en)
|
2020-12-31 |
2022-07-07 |
Immatics US, Inc. |
Cd8 polypeptides, compositions, and methods of using thereof
|
|
CN115975003B
(zh)
*
|
2021-03-09 |
2024-01-26 |
科士华(南京)生物技术有限公司 |
Tcr、多肽、表达载体、宿主细胞、药物组合物和tcr获得方法
|
|
EP4326751A1
(en)
*
|
2021-04-21 |
2024-02-28 |
The United States of America, as represented by the Secretary, Department of Health and Human Services |
Hla class i-restricted t cell receptors against ras with q61k mutation
|
|
BR112023022975A2
(pt)
|
2021-05-05 |
2024-01-23 |
Immatics Biotechnologies Gmbh |
Polipeptídeos de ligação ao antígeno bma031 melhorados
|
|
CN113337514B
(zh)
*
|
2021-08-05 |
2021-10-29 |
卡瑞济(北京)生命科技有限公司 |
Tcr表达构建体以及其制备方法和用途
|
|
WO2023044488A1
(en)
|
2021-09-20 |
2023-03-23 |
Immatics US, Inc. |
Monocyte depletion of t cells populations for t-cell therapy
|
|
CN113773378B
(zh)
*
|
2021-10-14 |
2023-11-03 |
深圳大学总医院 |
T细胞受体及其应用
|
|
CN119798440A
(zh)
*
|
2021-11-03 |
2025-04-11 |
同润生物医药(上海)有限公司 |
新型抗l1cam抗体
|
|
WO2023081925A1
(en)
|
2021-11-08 |
2023-05-11 |
Immatics Biotechnologies Gmbh |
Adoptive cell therapy combination treatment and compositions thereof
|
|
US20230142468A1
(en)
|
2021-11-08 |
2023-05-11 |
Immatics US, Inc. |
Methods for generating cell spheroids
|
|
US20250154503A1
(en)
|
2022-01-14 |
2025-05-15 |
Tune Therapeutics, Inc. |
Compositions, systems, and methods for programming t cell phenotypes through targeted gene repression
|
|
US20250134999A1
(en)
|
2022-01-14 |
2025-05-01 |
Tune Therapeutics, Inc. |
Compositions, systems, and methods for programming t cell phenotypes through targeted gene activation
|
|
WO2023148494A1
(en)
*
|
2022-02-03 |
2023-08-10 |
University College Cardiff Consultants Limited |
Novel t-cell receptor
|
|
WO2023183758A2
(en)
*
|
2022-03-19 |
2023-09-28 |
Regeneron Pharmaceuticals, Inc. |
Multispecific molecules targeting cd3 and mage-a4 and uses thereof
|
|
WO2023212691A1
(en)
|
2022-04-28 |
2023-11-02 |
Immatics US, Inc. |
DOMINANT NEGATIVE TGFβ RECEPTOR POLYPEPTIDES, CD8 POLYPEPTIDES, CELLS, COMPOSITIONS, AND METHODS OF USING THEREOF
|
|
KR20250018168A
(ko)
|
2022-04-28 |
2025-02-04 |
이매틱스 유에스 인코포레이티드 |
막-결합된 il-15, cd8 폴리펩티드, 세포, 조성물, 및 이의 사용 방법
|
|
EP4514821A1
(en)
|
2022-04-28 |
2025-03-05 |
Immatics US, Inc. |
Il-12 polypeptides, il-15 polypeptides, il-18 polypeptides, cd8 polypeptides, compositions, and methods of using thereof
|
|
US20230355678A1
(en)
|
2022-05-05 |
2023-11-09 |
Immatics US, Inc. |
Methods for improving t cell efficacy
|
|
CA3260344A1
(en)
*
|
2022-06-24 |
2023-12-28 |
Amgen Inc. |
MAGEA4-SPECIFIC T-LYMPHOCYTE RECEPTORS
|
|
WO2024036166A1
(en)
*
|
2022-08-08 |
2024-02-15 |
The University Of North Carolina At Chapel Hill |
Bioorthogonal t cell receptor molecules and methods of making and using the same
|
|
WO2024064642A2
(en)
|
2022-09-19 |
2024-03-28 |
Tune Therapeutics, Inc. |
Compositions, systems, and methods for modulating t cell function
|
|
WO2025029840A1
(en)
|
2023-07-31 |
2025-02-06 |
Tune Therapeutics, Inc. |
Compositions and methods for multiplexed activation and repression of t cell gene expression
|
|
WO2025029835A1
(en)
|
2023-07-31 |
2025-02-06 |
Tune Therapeutics, Inc. |
Compositions and methods for modulating il-2 gene expression
|
|
US20250134931A1
(en)
|
2023-11-01 |
2025-05-01 |
Immatics US, Inc. |
Membrane-bound il-15, cd8 polypeptides, cells, compositions, and methods of using thereof
|
|
WO2025233420A1
(en)
|
2024-05-07 |
2025-11-13 |
Immatics Biotechnologies Gmbh |
Use of anti-cancer molecules
|